| P50 | author | David R Cotter | Q63874461 |
| P2093 | author name string | Melanie Föcking | |
| | Kieran Wynne | |
| | Klaus Oliver Schubert | |
| P2860 | cites work | Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus | Q44793041 |
| | Regulation of striatal tyrosine hydroxylase phosphorylation by acute and chronic haloperidol | Q45014695 |
| | Reduced cortical volume and elevated astrocyte density in rats chronically treated with antipsychotic drugs-linking magnetic resonance imaging findings to cellular pathology | Q45039281 |
| | Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically | Q45120222 |
| | 2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease | Q46661063 |
| | Chronic treatment of haloperidol induces pathological changes in striatal neurons of guinea pigs: a light and electron microscopical study | Q46751574 |
| | The brain metabolic patterns of clozapine- and fluphenazine-treated female patients with schizophrenia: evidence of a sex effect | Q48093348 |
| | Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure | Q48153941 |
| | Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography | Q48609948 |
| | Haloperidol and cerebral metabolism in the conscious rat: relation to pharmacokinetics | Q48624810 |
| | Increased brain dopamine and dopamine receptors in schizophrenia. | Q48903689 |
| | Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation. | Q55053712 |
| | 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms | Q57781187 |
| | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| | The molecular motor toolbox for intracellular transport | Q28211349 |
| | Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis | Q28293647 |
| | ProteomeXchange provides globally coordinated proteomics data submission and dissemination | Q29614806 |
| | Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia | Q29618963 |
| | Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex | Q31864319 |
| | Early exposure to haloperidol or olanzapine induces long-term alterations of dendritic form | Q33594620 |
| | Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. | Q33814201 |
| | Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3. | Q33887879 |
| | Anatomy of bipolar disorder and schizophrenia: a meta-analysis. | Q34092580 |
| | Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia | Q34383654 |
| | Antipsychotic drug effects on brain morphology in first-episode psychosis | Q34408860 |
| | Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia | Q34482389 |
| | New model of action for mood stabilizers: phosphoproteome from rat pre-frontal cortex synaptoneurosomal preparations | Q34729740 |
| | Structural regulation of cullin-RING ubiquitin ligase complexes | Q35151712 |
| | Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers | Q35770186 |
| | The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia | Q35974169 |
| | Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics | Q36281844 |
| | What's driving false discovery rates? | Q37032521 |
| | Target identification for CNS diseases by transcriptional profiling. | Q37175279 |
| | Long-term oral methylphenidate treatment in adolescent and adult rats: differential effects on brain morphology and function. | Q37409615 |
| | Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia | Q37441628 |
| | Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia | Q37636593 |
| | White matter neuron alterations in schizophrenia and related disorders | Q37778420 |
| | Microtubule-associated protein MAP2 expression in olfactory bulb in schizophrenia | Q38336055 |
| | Adolescent Risperidone treatment alters protein expression associated with protein trafficking and cellular metabolism in the adult rat prefrontal cortex | Q38432171 |
| | A comparative study of MAP2 immunostaining in areas 9 and 17 in schizophrenia and Huntington chorea | Q43186910 |
| | BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs | Q43698142 |
| | Atypical neuroleptics stimulate neurogenesis in adult rat brain | Q44059818 |
| | Cerebral metabolism and risperidone treatment in schizophrenia | Q44264699 |
| | Comparative analysis of acute and chronic administration of haloperidol and clozapine using [3H] 2-deoxyglucose metabolic mapping | Q44428868 |
| | CAND1-dependent control of cullin 1-RING Ub ligases is essential for adipogenesis | Q44431558 |
| | Clozapine but not haloperidol Re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex | Q44603419 |
| | Differential effects of typical and atypical neuroleptics on mitochondrial function in vitro | Q44684238 |
| | Hippocampal volume and cell proliferation after acute and chronic clozapine or haloperidol treatment | Q44721396 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | haloperidol | Q251347 |
| P304 | page(s) | 532-538 | |
| P577 | publication date | 2016-01-13 | |
| P1433 | published in | Proteomics | Q15614164 |
| P1476 | title | Proteome and pathway effects of chronic haloperidol treatment in mouse hippocampus | |
| P478 | volume | 16 | |